After patients enrol in clinical trials, regular assessments and testing – often requiring clinic visits – can become onerous and reduce the chances they will stick with t
In the realm of architectural and construction innovation for healthcare, the NHS is grappling with a formidable challenge: the prolonged backlog for a spectrum of vital medical services an
Novo Nordisk's anti-TFPI antibody concizumab has been backed for approval in the EU as a once-daily drug to prevent bleeding episodes in people with haemophilia.